Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

Zekai Tahir Burak Women's Health Research and Education Hospital

Status: Completed

Conditions: Sepsis

Study type: Observational

Funder types: Other

Identifiers

NCT01362504

ZTB0663

Details and patient eligibility

About

The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.

Enrollment: 80 estimated patients

Sex: All

Ages: 24 to 42 weeks old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinical sepsis and/or proven sepsis.

Exclusion criteria

• Acute kidney injury
• Intracranial hemorrhage (Grade III and IV)

Trial design

80 participants in 3 patient groups

Clinical sepsis

Proven sepsis

Control group

Description:

healthy neonates